If CheckVacc works then that means it hunts down and infects tumour cell. That's half the equation needed for onCARlytics to work. I got into IMU for the B Cell platform but I'm very much looking forward to the results for CheckVacc and later onCARlytics. I'd expect substantial BP interest if CheckVacc shows any kind of efficacy due to the positive implications for onCARlytics.
Ann: Imugene to present at NWR virtual investor conference, page-154
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.6¢ |
Change
0.004(4.88%) |
Mkt cap ! $618.5M | |||
| Open | High | Low | Value | Volume |
| 8.2¢ | 8.7¢ | 8.1¢ | $1.488M | 17.61M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 1427245 | 8.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.6¢ | 382929 | 14 |
View Market Depth
| Last trade - 13.30pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
8.7¢ |
Change
0.004 ( 5.84 %) |
||||
| Open | High | Low | Volume | ||
| 8.2¢ | 8.7¢ | 8.2¢ | 6277334 | ||
| Last updated 13.54pm 30/04/2024 ? | |||||
| IMU (ASX) Chart |